A team of researchers from University of Florida Health has developed an open-access AI tool to accelerate the diagnosis of acute leukemias, according to a study published July 29 in Nature Communications. The Acute Leukemia Methylome Atlas, or ALMA, maps…
The Latest
As the medical school landscape shifts in response to federal pressures and new demands in the healthcare space — such as technological advancements, AI and drug innovations — new physicians may be entering the field with gaps in their clinical…
Between 2010 and 2019, incidence rates of 14 cancers increased among individuals younger than 50, with “concerning increases” reported in colorectal and uterine cancer mortality. While the statistics may raise alarm, one oncology expert is encouraging healthcare leaders to understand…
Imagine a future where some cancers are caught before symptoms appear, before they spread, before lives are disrupted. That’s the potential of multi-cancer early detection (MCED), a transformative approach that’s reshaping how healthcare leaders think about cancer screening. In 2025 alone,…
New York City-based NYU Langone Health’s Perlmutter Cancer Center has appointed two leaders for its newly established Gastrointestinal Cancer Center. Anirban Maitra, MD, and Manuel Hidalgo, MD, will serve as co-directors of the center, according to a Sept. 5 news…
The 2022 merger of Charlotte, N.C.-based Atrium Health and Advocate Aurora Health, then dually based in Downers Grove, Ill., and Milwaukee, created one of the largest nonprofit health systems in the country in Advocate Health. “We are poised to push…
Atlantic City, N.J.-based AtlantiCare has appointed Kay Yoon-Flannery, DO, as chief of women’s oncology at the AtlantiCare Cancer Care Institute in Egg Harbor Township, N.J.. She will lead alignment of breast, gynecologic and genetic cancer services across the system, according…
University Hospitals’ Seidman Cancer Center has received a $3.5 million gift to support efforts to triple capacity for clinical trials within the next five years. The gift comes from Kathy Coleman, who has donated more than $14 million to the…
Despite breakthroughs in drug therapies and diagnostic technologies, prostate cancer incidence in the U.S. has increased 3.0% per year. At the same time, prostate cancer mortality is declining at a slower rate than the previous two decades. As chief clinical…
A urine-based biomarker panel detected prostate cancer in 91% of specimens with a diagnostic accuracy of 78.6% to 85.7%, according to a study published Sept. 2 in eBioMedicine. Led by a team from Baltimore-based Johns Hopkins Kimmel Cancer Center and…